Trade CNTA anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Centessa Pharmaceuticals plc American Depositary Shares (CNTA) is trading at US$40.50, up 0.00% today as of Aug 27, 16:00 EDT. The company has a market capitalisation of US$6.27B. Over the past 52 weeks, CNTA has traded between US$15.01 and US$40.56. On Syfe you can trade CNTA with $0 commission and add it to your watchlist.
| Previous close | US$40.50 |
|---|---|
| Market cap | US$6.27B |
| 52-week range | US$15.01 – US$40.56 |
| Volume | 11.33M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Centessa Pharmaceuticals plc American Depositary Shares
Centessa Pharmaceuticals Plc operates as clinical-stage pharmaceutical company, which engages in the discovery, development, and delivery of medicines that are transformational for patients. It is primarily focused on developing orexin receptor agonists for neurological and neurodegenerative disorders, including programs targeting narcolepsy, idiopathic hypersomnia, and other neuropsychiatric conditions, as well as its early-stage LockBody immuno-oncology platform. The company was founded on October 26, 2020 and is headquartered in Altrincham, the United Kingdom.
Year: 2021
Eli Lilly Completes Acquisition of Centessa Pharmaceuticals
Jun 24, 2:32 PM · MT Newswires
UK High Court Approves Lilly's $7.8 Billion Acquisition of Centessa
Jun 22, 8:25 PM · MT Newswires
Update: Market Chatter: Eli Lilly Plans to Sell About $8 Billion of Bonds to Fund Acquisitions
May 6, 3:35 PM · MT Newswires
Market Chatter: Eli Lilly Plans to Sell About $8 Billion of Bonds to Fund Acquisitions
May 6, 2:15 PM · MT Newswires
Wells Fargo Downgrades Centessa Pharmaceuticals ADR to Equal Weight From Overweight, Adjusts Price Target to $42 From $35
Apr 20, 11:34 AM · MT Newswires
Stay on top of CNTA
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
